总时间（秒）：6.58
问答时间（秒）：4.53

```json
{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "Parkin",
        "Protein_Change": {
          "ref": "C289G",
          "alt": "None",
          "position": "117"
        },
        "variant_string_id": "C289G"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Define the disease mechanism",
          "extracted_paper_info": "The authors state that mutations in Parkin, particularly the C289G mutation, can disrupt protein folding and aggregation, leading to the formation of Lewy bodies.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly describes the role of the C289G mutation in the formation of Lewy bodies, highlighting its potential to disrupt protein folding."
        },
        {
          "step_name": "Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper emphasizes the use of proteomic assays, specifically looking for protein aggregation, as a diagnostic tool for Parkin mutations.",
          "judgment": "Yes",
          "reasoning": "The paper states the use of proteomic assays to assess the aggregation of Parkin protein."
        },
        {
          "step_name": "Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The authors discuss the use of 'protein aggregation' as a key indicator for Parkin mutations, highlighting that the assay effectively measures the disruption of protein folding.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly links the use of a protein aggregation assay to the detection of Parkin mutations."
        },
        {
          "step_name": "Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The authors mention that the test will use the 'protein aggregation' assays.",
          "judgment": "Yes",
          "reasoning": "The test's purpose is to evaluate the impact of the mutation on protein aggregation."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The C289G mutation of Parkin is a significant driver of Lewy body formation, leading to significant aggregation and subsequent dysfunction of the protein."
    }
  ]
}
```